Add BrightSurf on Google Email

CHOP researchers use “deep sequencing” to identify several previously undescribed genetic variants in vascular anomalies

CHOP researchers used deep sequencing to discover several previously undescribed genetic variants in vascular anomalies, capturing low-frequency mutations that were missed by conventional methods. The study found significant improvements in symptoms for over 63% of patients, enabling targeted therapies and improved quality of life.

SourceChildren's Hospital of Philadelphia·JournalNature Medicine·TypeExperimental study·DateJun 1, 2023

Accurate detection of low-level somatic mutation in intractable epilepsy

Researchers developed an advanced method to detect low-level somatic mutations in intractable epilepsy with 100% accuracy, surpassing conventional sequencing analysis which stands at 30%. The study used deep sequencing replicates of major focal epilepsy genes and identified mutations in approximately 5% of patients.

Diving deeper into the gene pool

Tel Aviv University researchers developed miRNAkey software to analyze microRNA patterns in healthy and diseased tissues, improving understanding of human diseases at a genetic level. The software enables scientists to identify relevant microRNAs, determine their levels, and generate statistically valuable information.

SourceAmerican Friends of Tel Aviv University·JournalBioinformatics·DateSep 27, 2010